D360™ will provide enhanced data access and visualization to enable rapid decision making and reduce attrition rates ST. LOUIS, MO – June 4, 2014 – Certara®, the leading global technology-enabled drug development and drug safety consultancy, announced today that a top 5 Global Pharma company has selected Certara’s D360 as its global drug discovery platform. … Continued
In this webinar, David Lowis, D. Phil. of Certara, makes the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Joining Dr. Lowis will be Stuart Horowitz, PhD, President of Institutional Services at WIRB-Copernicus Group. Dr. Horowitz … Continued
D360™ will provide enhanced data access and visualization, permitting closer collaboration between Medivir’s discovery scientists ST. LOUIS, MO – Jan. 27, 2014 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Medivir AB, a Swedish pharmaceutical company that focuses … Continued
Certara customers will now be able to view curated life sciences content from Thomson Reuters Cortellis™ alongside their proprietary scientific data ST. LOUIS, MO – October 22, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that it is … Continued
D360™ will permit chemical structure and related biological property data to be shared between global sites. ST. LOUIS, MO – Oct. 17, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that the pharmaceutical company Boehringer Ingelheim has chosen … Continued
Bio-IT World News Bulletin describes how Pfizer has adopted D360 as Pfizer’s core research platform. ST. LOUIS, MO – July 29, 2013 Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that Pfizer selected Certara’s D360™ software solution for scientific data access … Continued
Certara’s D360 to offer access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle. ST. LOUIS, MO – March 19, 2013 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that Certara and ChemAxon have signed a partnership agreement. The partnership will focus on … Continued
Certara’s latest version of D360 adds important user desired features to support enhanced scientific data access and analysis. ST. LOUIS, MO – February 27, 2013 – Certara™, a leading provider of scientific software and consulting services to improve productivity and decision-making from drug discovery through clinical development, is pleased to announce the next major release … Continued
Certara’s D360 to offer access to Thomson Reuters’s Cortellis to integrate internal with external data ST. LOUIS, MO – January 15, 2013 – Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that Certara and Thomson Reuters have signed a partnership agreement. The … Continued
D360 allows Plexxikon’s researchers to easily query and analyze biological assay and chemical registration data from a single dashboard. ST. LOUIS, MO – December 5, 2012 – Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that Plexxikon selected Certara’s D360™ software solution for scientific data … Continued
